TickerFacts.

GT Biopharma, Inc. (GTBP): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-30, first reflected in a filing dated 2024-03-26. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Figures left out. The filed Weighted Average Diluted Shares for the year ended 2018-12-31 is not shown: share count out of scale with net income per share. That usually means the filing tagged the figure in the wrong unit.

5.51M
Year ended 2025-12-31
+73.1%
3-year compound annual growth
16.77M2015-12-31: 2.39M2016-12-31: 81.5K2017-12-31: 16.77M2019-12-31: 3.38M2020-12-31: 4.39M2022-12-31: 1.06M2023-12-31: 1.35M2024-12-31: 1.90M2025-12-31: 5.51M5.51M
2015-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-315.51M+190.6%2026-03-02, From 2025-01-01
2024-12-311.90M+40.8%2026-03-02, From 2024-01-01
2023-12-311.35M+26.9%2025-02-21, From 2023-01-01
2022-12-311.06Mn/c2024-03-26, From 2022-01-01
No annual figure between 2020-12-31 and 2022-12-31.
2020-12-314.39M+29.6%2021-04-16, From 2020-01-01
2019-12-313.38Mn/c2021-04-16, From 2019-01-01
No annual figure between 2017-12-31 and 2019-12-31.
2017-12-3116.77Mn/m2018-03-01, From 2017-01-01
2016-12-3181.5K-96.6%2018-03-01, From 2016-01-01
2015-12-312.39Mn/a2018-02-28, From 2015-01-01